Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260–270 (2012).
CAS PubMed PubMed Central Article Google Scholar
Malla, M. A. et al. Exploring the human microbiome: the potential future role of next-generation sequencing in disease diagnosis and treatment. Front. Immunol. 9, 2868 (2018).
CAS PubMed Article Google Scholar
NIH Human Microbiome Portfolio Analysis Team. A review of 10 years of human microbiome research activities at the US National Institutes of Health, fiscal years 2007–2016. Microbiome 7, 31 (2019).
Clarke, G. et al. Minireview: gut microbiota: the neglected endocrine organ. Mol. Endocrinol. 28, 1221–1238 (2014).
PubMed PubMed Central Article CAS Google Scholar
Oliphant, K. & Allen-Vercoe, E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome 7, 91 (2019).
PubMed PubMed Central Article Google Scholar
Fulde, M. & Hornef, M. W. Maturation of the enteric mucosal innate immune system during the postnatal period. Immunol. Rev. 260, 21–34 (2014).
CAS PubMed Article Google Scholar
Kamada, N., Chen, G. Y., Inohara, N. & Nunez, G. Control of pathogens and pathobionts by the gut microbiota. Nat. Immunol. 14, 685–690 (2013).
CAS PubMed PubMed Central Article Google Scholar
Ijssennagger, N. et al. Gut microbiota facilitates dietary heme-induced epithelial hyperproliferation by opening the mucus barrier in colon. Proc. Natl Acad. Sci. USA 112, 10038–10043 (2015).
CAS PubMed PubMed Central Article Google Scholar
Reinhardt, C. et al. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 483, 627–631 (2012).
CAS PubMed Article Google Scholar
Neuman, H., Debelius, J. W., Knight, R. & Koren, O. Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiol. Rev. 39, 509–521 (2015).
Yano, J. M. et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161, 264–276 (2015).
CAS PubMed PubMed Central Article Google Scholar
Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577–591 (2015).
CAS PubMed Article Google Scholar
Tuddenham, S. & Sears, C. L. The intestinal microbiome and health. Curr. Opin. Infect. Dis. 28, 464–470 (2015).
CAS PubMed PubMed Central Article Google Scholar
Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369–2379 (2016).
CAS PubMed Article Google Scholar
Durack, J. & Lynch, S. V. The gut microbiome: relationships with disease and opportunities for therapy. J. Exp. Med. 216, 20–40 (2019).
CAS PubMed PubMed Central Article Google Scholar
Sokol, H. et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. USA 105, 16731–16736 (2008).
CAS PubMed PubMed Central Article Google Scholar
Schirmer, M. et al. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nat. Microbiol. 3, 337–346 (2018).
CAS PubMed PubMed Central Article Google Scholar
Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
CAS PubMed PubMed Central Article Google Scholar
Fujimura, K. E. & Lynch, S. V. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe 17, 592–602 (2015).
CAS PubMed PubMed Central Article Google Scholar
Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480–484 (2009).
CAS PubMed Article Google Scholar
Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
Larsen, N. et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5, e9085 (2010).
Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60 (2012).
CAS PubMed Article Google Scholar
Marin, I. A. et al. Microbiota alteration is associated with the development of stress-induced despair behavior. Sci. Rep. 7, 43859 (2017).
PubMed PubMed Central Article Google Scholar
Kang, D. W. et al. Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study. Microbiome 5, 10 (2017).
PubMed PubMed Central Article Google Scholar
Clapp, M. et al. Gut microbiota’s effect on mental health: the gut-brain axis. Clin. Pract. 7, 987 (2017).
PubMed PubMed Central Article Google Scholar
Wilkins, L. J., Monga, M. & Miller, A. W. Defining dysbiosis for a cluster of chronic diseases. Sci. Rep. 9, 1–10 (2019).
Moe, O. W. Kidney stones: pathophysiology and medical management. Lancet 367, 333–344 (2006).
CAS PubMed Article Google Scholar
Robertson, W. G., Peacock, M., Marshall, R. W., Marshall, D. H. & Nordin, B. C. Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. N. Engl. J. Med. 294, 249–252 (1976).
CAS PubMed Article Google Scholar
Kaufman, D. W. et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J. Am. Soc. Nephrol. 19, 1197–1203 (2008).
CAS PubMed PubMed Central Article Google Scholar
Sidhu, H. et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352, 1026–1029 (1998).
CAS PubMed Article Google Scholar
Kumar, R. et al. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur. Urol. 41, 318–322 (2002).
CAS PubMed Article Google Scholar
Duncan, S. H. et al. Oxalobacter formigenes and its potential role in human health. Appl. Environ. Microbiol. 68, 3841–3847 (2002).
CAS PubMed PubMed Central Article Google Scholar
Allison, M. J., Dawson, K. A., Mayberry, W. R. & Foss, J. G. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch. Microbiol. 141, 1–7 (1985).
CAS PubMed Article Google Scholar
Miller, A. W. & Dearing, D. The metabolic and ecological interactions of oxalate-degrading bacteria in the mammalian gut. Pathogens 2, 636–652 (2013).
CAS PubMed PubMed Central Article Google Scholar
Campieri, C. et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int. 60, 1097–1105 (2001).
CAS PubMed Article Google Scholar
Turroni, S. et al. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J. Appl. Microbiol. 103, 1600–1609 (2007).
CAS PubMed Article Google Scholar
Turroni, S. et al. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: impact of acidic conditions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes. Appl. Environ. Microbiol. 76, 5609–5620 (2010).
CAS PubMed PubMed Central Article Google Scholar
Batagello, C. A., Monga, M. & Miller, A. W. Calcium oxalate urolithiasis: a case of missing microbes? J. Endourol. 32, 995–1005 (2018).
留言 (0)